Oligonucleotide chip for detection of Lamivudine-resistant hepatitis B virus (Q37511150)

20 August 2017

Oligonucleotide chip for detection of Lamivudine-resistant hepatitis B virus (English)

1 reference

20 August 2017

1 reference

1 reference

2

Mong Cho

1 reference

20 August 2017

Hyunjung Jang

1

1 reference

20 August 2017

Jeong Heo

3

1 reference

20 August 2017

Hyunghoi Kim

4

1 reference

20 August 2017

Hongki Jun

5

1 reference

20 August 2017

Woowon Shin

6

1 reference

20 August 2017

Byungman Cho

7

1 reference

20 August 2017

Heekyung Park

8

1 reference

20 August 2017

Cheolmin Kim

9

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Journal of Clinical Microbiology

20 August 2017

1 reference

20 August 2017

42

1 reference

20 August 2017

9

1 reference

20 August 2017

4181-4188

1 reference

Management of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B.

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Identification of Listeria species by microarray-based assay

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral hepatitis B.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Detection and genotyping of human group A rotaviruses by oligonucleotide microarray hybridization

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Lamivudine resistance in hepatitis B: mechanisms and clinical implications

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Microarray analysis of microbial virulence factors

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Detection of hepatitis B virus resistance to antivirals

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Emergence of YMDD motif mutant of hepatitis B virus during short-term lamivudine therapy in South Korea

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Detection and identification of Mycobacterium species isolates by DNA microarray

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Detection of hepatitis B virus polymerase variations resistant to lamivudine therapy.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516280

10.1128/JCM.42.9.4181-4188.2004

2 September 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

15365009

1 reference